FDA Sets Higher Than Expected Fiscal 2013 Generic Facility Fees, Payment Due March 4

January 17, 2013
The FDA has laid out the first set of generic-drug user fees for facilities, setting a March 4 deadline for payment. The FDF fees are higher than originally anticipated, due to the lower-than-expected amount of facilities that self-identified and will now share the costs. The FDA previously predicted the fee for API facilities would be roughly $35,000 and the fee for FDF facilities would be roughly $150,000.
Drug Industry Daily